Niger

in page functions
[French]
Niger
Total population (2018) 22,445,303
Birth cohort (2018) 1,091,177
Surviving Infants (surviving to 1 year per year, 2018) 1,037,234
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 57/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 96/1000
World Bank Index, IDA (2015) 3.46
Gross Nation Income (per capita US$, 2015) 390
No. of districts/territories (2017) 72

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Niger

Type of support

Approvals

2001-2023 (US$)
(29 Mar 2019)

Commitments

2001-2023 (US$)
(29 Mar 2019)

Disbursements

2000-2018 (US$)
(29 Mar 2019)

% Disbursed

(29 Mar 2019)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $201,299,190 $225,938,890 $183,919,991
Cash Support (CASHSUPP) $235,000 $260,000 $235,000 100%
Cold Chain Equipment Optimisation Platform (CCEOP) $2,984,274 $2,984,274 $1,848,464 62%
Health system strengthening (HSS 1) $3,533,902 $3,533,902 $3,533,902 100%
Health system strengthening (HSS 2) $32,412,892 $40,025,092 $24,655,657 76%
HPV Demo (NVS) $599,142 $599,142 $610,200 102%
Immunisation services support (ISS) $7,398,724 $7,398,724 $7,398,724 100%
Injection Safety Devices (NVS) $1,029,959 $1,431,959 $610,136 59%
Injection safety support (INS) $943,757 $943,757 $943,757 100%
IPV (NVS) $5,652,846 $5,652,846 $3,829,011 68%
Meningitis A (NVS) $956,000 $1,340,000 $1,018,768 107%
Meningitis A - mini catch-up campaign (NVS) $5,065,575 $5,065,575 $5,065,575 100%
Meningitis A - mini catch-up op.costs (OPC) $3,947,321 $3,947,321
Penta (NVS) $46,681,399 $48,345,899 $46,652,035 100%
Pneumo (NVS) $58,707,691 $67,988,691 $57,908,442 99%
Product Switch Grant (PSG) $240,500 $240,500 $240,330 100%
Rotavirus (NVS) $20,616,795 $24,794,795 $18,411,428 89%
Vaccine Introduction Grant (VIG) $3,594,000 $3,594,000 $3,586,231 100%
Yellow Fever (NVS) $6,699,413 $7,792,413 $7,372,331 110%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Niger DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 93%
M:F sex ratio at birth (2018) 1.05
Household survey: DTP3 coverage for male (2011) 67.50%
Household survey: DTP3 coverage for female (2011) 68.60%
Household survey: Last DTP3 survey (2011) 68%
% districts achieving > 80% DTP3 coverage (2017) 83%
% districts achieving < 50% DTP3 coverage (2017) 1%
MCV WHO/UNICEF estimates (2017) 78%

Breakdown of support

Non-vaccine support Vaccine support
23% 77%
$42,442,065 $141,477,926

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Niger

10 December 2018

MTR

UAE and Gavi convene leaders to focus on health for next generation

High-level meeting to review access to vaccines in low-income countries and how to accelerate impact.

27 September 2018

Gavi at the 73rd UNGA

Gavi at the UNGA: driving political leadership

The 73rd United Nations General Assembly (UNGA) is a critical gathering for global health, with representatives from across the Vaccine Alliance working together to improve the health and wellbeing for millions of people worldwide.

23 May 2018

DRC, Ebola vaccination

Gavi's response to the DRC Ebola outbreak

Statement to the 71st World Health Assembly

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here